As of 2025-09-16, the Relative Valuation of bluebird bio Inc (BLUE) is (276.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.97 USD, the upside of bluebird bio Inc based on Relative Valuation is -5669.2%.
The range of the Relative Valuation is (222.25) - (313.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 15.3x | 13.6x |
| Forward P/E multiples | 10.8x - 16.8x | 13.5x |
| Fair Price | (222.25) - (313.35) | (276.79) |
| Upside | -4571.8% - -6404.9% | -5669.2% |
| Date | P/E |